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The microRNA pathways govern complex interactions of the host and virus at the
transcripts level that regulate cellular responses, viral replication and viral pathogenesis.
As a group of single-stranded short non-coding ribonucleotides (ncRNAs), the microRNAs
complement their messenger RNA (mRNA) targets to effect post-transcriptional
or translational gene silencing. Previous studies showed the ability of human
immunodeficiency virus 1 (HIV-1) to encode microRNAs which modify cellular defence
mechanisms thus creating an environment favorable for viral invasion and replication.
In corollary, cellular microRNAs were linked to the alteration of HIV-1 infection at
different stages of replication and latency. As evidences further establish the regulatory
involvement of both cellular and viral microRNA in HIV-1-host interactions, there is a
necessity to organize this information. This paper would present current and emerging
knowledge on these multi-dimensional interactions that may facilitate the design of
microRNAs as effective antiretroviral reagents.
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INTRODUCTION
The human immunodeficiency virus 1 (HIV-1) is the retroviral
agent causing acquired immunodeficiency syndrome (AIDS), a
disease leading to systemic failure of the immune system with life
threatening consequences. The decades old magnanimous prob-
lem of HIV-1 infection has challenged researchers to address its
control and eradication. One of the most recent strategies intro-
duced is the use of small non-coding ribonucleotides (ncRNAs)
which includes microRNAs (Arbuthnot, 2011). The microRNAs
are ubiquitous ∼22–25 nt endogenously expressed ncRNAs tar-
geting specific messenger RNA (mRNA) sequences, thus inducing
its degradation or effecting translational inhibition. As proven
vital regulatory components of viral infection and immunity
(Huang et al., 2011), microRNAs can be directed to target viral
and cellular transcripts to suppress infection. In fact, numer-
ous studies have been proposed to integrate cellular microRNAs
as nucleotide-based therapy for HIV (Boden et al., 2004; Lo
et al., 2007; Aagaard et al., 2008). However, HIV-1 is a fas-
tidious mutant consequently making cellular microRNAs prone
to losing its viral transcript target efficacy as constant genome
revisions occur in the course of viral evolution. Thus, simulta-
neous expression of microRNAs aimed to repress multiple HIV-1
targets may deter the effects of escape mutants. In another sce-
nario, the cellular microRNAs can target host gene products that
regulate cell defense responses. Once the issues of microRNA off-
target effects, cell toxicity and delivery systems are addressed,
the development of microRNAs as an anti-HIV-1 therapeutic
strategy becomes more realistic (Boden et al., 2007; Liu et al.,
2011). Now, the greater challenge is to determine the specific
roles of the current inventory of 1921 human and three HIV-
1 microRNAs (Kozomara and Griffiths-Jones, 2011) in HIV-1
infection. This difficult task of functional assignments corre-
lated tomicroRNA-mRNA interactions has beenmade easier with
genomics-based predictive tools in the recent years (Tan Gana
et al., 2012). In addition, significant improvements on techniques
for microRNA discovery and functional elucidation are likely to
further expand these emerging interactive networks.
Whereas the current knowledge on cellular and viral
microRNA functions involved in HIV-1 infection is still con-
siderably few, consensus evidences suggest complex interactions
(Chiang and Rice, 2011; Sanchez-Del Cojo et al., 2011). Figure 1
implies that microRNA regulation is anchored on genomic infor-
mation processing on four scenarios that may possibly explain
the confounded nature of their effects in virus-infected host sys-
tems. First, HIV-1 infection alters host microRNA networks to
initiate successful viral invasion and latency, thus, affecting global
host microRNA regulome. Second, HIV-1 microRNAs are pro-
duced from both sense and antisense transcripts to target either
its own viral transcript or host genes for immune compromise.
Third, the host microRNA systems may consequentially target
the HIV-1 genomic elements or its genes to innate immune
responses. Fourth, the interplay of microRNA and target mRNA
between host and HIV-1 can be organized into regulatory mod-
ules (cis- and trans- regulation) of essential biochemical pathways
as critical determinants of host cell fate and survival. This frame-
work would be the basis of our paper discussion covering an
update on the current information on microRNA biogenesis and
mechanisms involved in host-virus interactions. Also the paper
would contain recently elucidated cellular and viral microRNA
functions in HIV-1 infection from computational and experi-
mental literature. Lastly, the integration of information would
define future roles of microRNAs in HIV-1 control.
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FIGURE 1 | The prospective targeting interactions of HIV-1 and cellular
microRNAs (modified from Cullen, 2006). The interactions among HIV-1
and cellular microRNAs with their corresponding targets may occur in several
modules. For instance, HIV-1 encoded microRNAs processed via the host
RNAi machinery and incorporated into RISC (in green with the mature
microRNA in red) are sourced from HIV-1 pro-viral strands (grey double helix)
initially from precursor microRNAs (red lines with poly adenines). These HIV-1
microRNAs can target its viral transcripts or the cellular transcripts. The
targeting interactions of microRNAs are shown in solid light arrow lines. In
corollary, cellular microRNAs derived from precursor microRNAs (red lines
with poly adenines) generated by the host cell genome (grey double helix).
The host cellular microRNAs are encoded in the same manner and can target
both viral and cellular transcripts where the targeting interactions are shown
in solid bold arrow lines. The targeting of mRNA transcripts happens in a
highly specific Watson and Crick base-pairing with either complete
complementation or seed region complementarity. The box in bold broken
lines consolidates all targeting events of the various microRNA-initiated
regulatory activities within the systems biology of host-virus interaction.
The type of microRNA silencing mechanisms may be grouped as a cis- and
trans-regulation event. The cis-regulation event involves microRNA targeting
of mRNAs initiating post-transcriptional regulatory responses via mRNA
degradation and translational inhibition. Whereas trans-regulation is a
tripartite regulatory event which include expression variation of microRNA
target genes regulating various viral and cellular activities such as
transcription factors, RNA regulatory proteins, interactive genes. The
cascades of events cause changes in viral and cellular activities inducing
transcriptional regulation, transcriptional variation and protein translational
modifications as indicated by the hollow circles = protein products;
X (in red) = regulation of expression. The HIV-1 components are
distinguished from host cell components with asterisks beside the drawings.
MicroRNA BIOGENESIS PATHWAYS AND MECHANISMS
The genomic locations of the microRNA gene progenitors of the
∼100 nt, 5′ methyl-7G capped and 3′ poly-adenylated primary-
microRNAs (pri-microRNA) transcribed by either RNA II or
III polymerase determine the mode of microRNA biogenesis
(Figure 2). The canonical pathway utilizes the microprocessor
complex, an interaction between Drosha RNase III enzyme (Faller
and Guo, 2008) and DiGeorge critical region gene 8 (DGCR8)
(Faller et al., 2010), a ribonuclease binding protein (RBP) to
cleave the pri-microRNA into 70 nt preliminary-microRNAs
(pre-microRNAs). While, a non-canonical pathway is followed
by mirtrons, a group of intron-derived pre-microRNAs utiliz-
ing spliceosomes (Okamura et al., 2007, 2008; Berezikov et al.,
2010). Recently, an emerging mode of biogenic pathway has
been proposed for a set of splicing-independent mirtrons called
simtrons which neither utilize DGCR8, Dicer, Exportin-5, or
Argonaute 2 (Ago2) in their biogenesis (Havens et al., 2012).
Then, the pre-microRNA associates with Ran/GTPase
(Bohnsack et al., 2004; Okada et al., 2009) and exportins for cyto-
plasmic translocation from nucleus (Bohnsack et al., 2004). In the
cytoplasm (Figure 3), catalytic hydrolysis of Ran/GTPase allows
the dissociation of pre-microRNA and transporter proteins (Kim,
2004). Another enzyme called Dicer, splices the pre-microRNA
into the mature ∼22 nt microRNA capable of mRNA duplexing
(Carmell and Hannon, 2004; Cullen, 2004; Hammond, 2005;
Harvey et al., 2008; Flores-Jasso et al., 2009). A complement
strand from the mature double stranded microRNA is integrated
into the RNA-induced silencing complex (RISC) which would be
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FIGURE 2 | Nuclear events of the integrated cellular and HIV-1 microRNA
biogenic pathways. The nucleus of the host cell is the central site of both
cellular and viral microRNA biogenesis. Initially, HIV-1 virion particles attach to
host cells via CD4 receptors signaling viral attack. This would be followed by
HIV-1 particle fusion with the cell membrane and uncoating to load its RNA
genome into the cytoplasm. The viral replicase enzyme facilitates production
of more RNA genome later to be shuttled into the nucleus for viral
transcription and integration into cellular genome. HIV-1 microRNA biogenesis
is synchronous to cellular microRNA production in the host cell nucleus where
other microRNA biogenic enzymes are present. Independent nuclear events
of miRNA biogenesis have several modes of pre-microRNA generation (viral
and cellular), initially from primary microRNA transcribed by either RNA
polymerase II or III. he canonical pathway is undertaken by intergenic
microRNAs resulting from microprocessor cleavage (Drosha and DGCR8) of
pri-microRNA transcripts into pre-microRNAs, An alternative pathway for
intron-coded microRNAs called mirtrons produce pre-microRNAs via splicing
by spliceosomes and debranching by lariat debranching enzyme (Ldbr). There
are three possible variants of mirtron processing, namely regular, the 5′ tailed
mirtrons (subject to nuclease processing) and 3′ tailed mirtons (subject to
exosome processing) (Westholm and Lai, 2011; Westholm et al., 2012). The
sections of these pre-microRNA variants are shown in different colors, which
the future main mature microRNAs are in blue, the secondary mature
microRNAs are in red, the loops in black, and the branches are in green. Once
generated, the pre-miRNAs are ready cytoplasmic shuttling, where further
processing into mature microRNAs are achieved. Lately, a new biogenic
pathway has been proposed for a set of splicing-independent mirtrons called
simtrons which independent from DGCR8, Dicer, Exportin-5, or Argonaute 2
(Ago2) (Havens et al., 2012) (not shown).
attached to the target transcript to elicit the regulatory processes
(Kawamata and Tomari, 2010).
The gene regulatory effects caused by the microRNA and
mRNA target interaction dictated by highly stringent base-
complementation of the binding sites have been demonstrated
extensively (Long et al., 2008; Brodersen and Voinnet, 2009;
Ajay et al., 2010). Perfect complementation of the microRNA
and mRNA causes endonucleolytic cleavage-induced gene silenc-
ing while non-perfect complementation initiate translational
inhibition of proteins (Jackson and Standart, 2007; Seitz, 2009;
Pan et al., 2010). Other factors shown to enhance these regu-
latory interactions include the presence of several binding sites
within the target mRNA and CTG repeats extension (Hon and
Zhang, 2007), deadenylation and decapping-mediated conforma-
tional changes within the microRNA-RISC complex (Lin et al.,
2005; Eulalio et al., 2007), the A-U bias (Frank et al., 2010) and
single nucleotide polymorphisms (SNPs) within the seed regions
(Landi et al., 2011).
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FIGURE 3 | Cytoplasmic events of the integrated cellular and HIV-1
microRNA biogenic pathways. Mature microRNAs are processed in the
host cytoplasm after the pre-microRNAs are shuttled from the nucleus. There
are two ways the processing can happen: (A) by the Dicer/TRBPorTARBP or
TARBP/PACT leading to the generation of microRNA duplexes, or (B) via the
Ago proteins-assisted generation of pre-cursor microRNA which in the end
generate the microRNA duplexes via Dicer action. The circular arrows
show the formation microRNA duplex produced after the circuitous
cleavage reactions of either Dicer, Ago2 proteins. Also shown in the
microRNAs duplexes are the representative seed sites in red and blue and
green indicates mismatches and bulges. Depending on the degree of
complementation of the guide strands in the microRNA:RISC assembly to its
target mRNA, would either cause mRNA degradation or translational
repression. Furthermore, microRNA duplexes undergoing asymmetric
unwinding would be assembled into the RISC loading complex after the
duplex unwinding by RNA helicase A (RHA, gray crescent), through a bypass
mechanism. Once the microRNA guide is loaded into the RISC associated
proteins (Dicer; TRBP; Ago2; PACT; GW182, not shown) forms the activated
microRNA:RISC to seek and bind targets within mRNA transcript. The mRNA
transcripts are shown with other components namely: methyl cap (in hollow
small circle), ribosome (hollow figure eight), and poly-A tail (AAAA). In HIV-1,
it was demonstrated that P-bodies modulate microRNA processing
mechanisms (Nathans et al., 2009). The solid gray pac-man indicates mRNA
degradation events.
Since, the viral genomic elements intersperse within the
host genome during invasion, it is possible that these viral
genomic fragments are processed into microRNAs by of the
host microRNA machinery (Figures 2, 3). As consequence, these
viral sequences will follow several pathways of microRNA bio-
genesis similar to its host. As example are the observed non-
significant differences among microRNA profiles in normalized
Dicer and Drosha expressions in HIV-1 infected CD4+ cells for
both in vitro and in vivo studies (Bignami et al., 2012). In contrast,
it was confirmed that microRNA expression among monocytes
could happen in the absence of the Dicer enzyme, thus, imply-
ing an alternative mode of viral microRNA production (Coley
et al., 2010). Another possible consequence of repeated integra-
tion and recombination of the HIV-1 into the host genome is
the generation of orthologous microRNAs. This is the case of
hiv1-miR-N367 and hsa-miR-192 with identical seed sequences
shown to down regulate similar functional targets in a dual flu-
orescent reporter study, thus, making them functional orthologs
(You et al., 2012).
ALTERATIONS IN THE CELLULAR MicroRNA PATHWAYS
DURING HIV-1 INFECTION
HIV-1 infection of host cells modifies the global RNA interfer-
ence machinery which in effect changes the microRNA-regulated
pathways via several bio-molecular interactions (Sanghvi and
Steel, 2011b). Experiments confirmed the RNA silencing sup-
pressor (RSS) activity of HIV-1 transactivator of transcrip-
tion (Tat) (Bivalkar-Mehla et al., 2011). RSS is defined as a
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molecule encoded by a virus which can counter the effect of
host cell microRNA-mediated antiviral defense pathways, or nat-
ural immunity (Houzet and Jeang, 2011). The HIV-1 Tat protein
via association with the trans-activation response (TAR) element
at the terminal 5′end of HIV-1 transcripts, promotes viral tran-
scription by recruiting and increasing the processivity of RNA
polymerase II (Hayes et al., 2011). The molecular complex cre-
ates a stabilizing effect on transcriptional elongation elicited by a
cyclin-dependent kinase (CDK9), another subunit of the positive
transcription elongation factor b (P-TEFb) together with Cyclin
T1 (CCNT1), which functions to phosphorylate the C-terminus
of RNA polymerase II (Sanghvi and Steel, 2011a). Also the bind-
ing between Tat protein to the TAR element blocks the TAR
element interaction with the Dicer protein thus influencing cel-
lular silencing mechanism (Bennasser and Jeang, 2006; Qian
et al., 2009). Further characterization of Tat protein exhibited two
most essential prerequisites for RSS activity, namely by harbor-
ing dsRNA binding domain (RKKRRQRR) and GW/WG motif
essential in sequestering Ago proteins thus preventing RISC for-
mation (Qian et al., 2009; Bivalkar-Mehla et al., 2011; Houzet
and Jeang, 2011). In another comparative gene expression profile
analysis between HIV-1 infected and non-infected macrophages,
it was showed that HIV-1-encoded Vpr (Viral Protein R) protein
similarly suppresses Dicer function (Coley et al., 2010). Table 1
includes the RNAi pathway related gene products that are tar-
geted by HIV-1 microRNAs. With the inherent small size of
Table 1 | List of published HIV-1 microRNAs and their target HIV-1 and cellular gene products.
HIV-1
microRNA
Name (A)
Mature sequence variants (B) Gene product
(mRNA)
targets (C)
Function of mRNA targets
(D)
References
hiv1-miR-TAR-5p 4-UCUCUCUGGUUAGACCAGAUCUGA-27 (Ra)
UGGGUCUCUGGUUAGACCAG (Bp)
GGUCUCUGGUUAGACCA (Nb)
GGGUCUCUCUGGUUAGACCA (Nb)
CUCUGGCUAACUACUAGGGAACCC (Ns)
UCUGGCUAACUACUAGGGAA (Ns)
UCUGGCUAACUACUAGGGAACCCA (Ns)
CUGGCUAACUACUAGGGAA (Ns)
UGGCUAACUACUAGGGAA (Ns)
UGGCUAACUACUAGGGAACCCAC (Ns)
UGGCUAACUACUAGGGAACCCACU (Ns)
UGGCUAACUACUAGGGAACCCACUG (Ns)
GGCUAACUACUAGGGAACCCACUG (Ns)
CUAACUACUAGGGAACCCACUGC (Ns)
LTR d
TAR d
RITS d
ERCC1(apo) d
IER3 (apo) d
Viral gene expression
Regulation/anti-apoptosis
Viral co-factor
Cell apoptotic factor
Cell apoptotic factor
Klase et al., 2007, 2009;
Ouellet et al., 2008;
Schopman et al., 2012
hiv1-miR-TAR-3p 38-UCUCUGGCUAACUAGGGAACCCA-60 (Ra)
CUAACUAGGGAACCCAC (Nb)
GCUAACUAGGGAACCCAC (Nb)
GCUAACUAGGGAACCCACUG (Nb)
TAR d
RITS d
Viral gene expression
Regulation/anti-apoptosis
Klase et al., 2007;
Schopman et al., 2012
hiv1-miR-H1 2-CCAGGG-AGGCGUGCCUGGGC-21 (Nb)
CCAGGG-AGGCGUGgCaUGGGC (Mc)
CCAGGG-AGGCGUGgCCUGGGC (Mc)
CCAGGG-AGGCGUGgCCUGGGC (Mc)
CCAuGGgAGGCGcGgCCUGGGC (Mc)
CCAGGG-AGGCGUGgCCgGGGu (Mc)
CCAGGGgAGGCGUGaCCUGGGC (Mc)
AATF d
BCL2 d
MYC d
PAWR d ;
DICER d
hsa-miR-194 d
Adaptive immunity
Activated cell
Proliferation regulator
Pro-viral latency
promoter
MicroRNA processing
Pre-microRNA
Processing/microRNA
binding
Kaul et al., 2009; Lamers
et al., 2010
hiv1-miR-N367 40-ACUGACCUUUGGAUGGUGCUUCAA-62
(Nb, Mc)
Nef d Transcription factor and
regulator
Omoto and Fujii, 2005
Notes: (A) The official names of microRNAs as published in mirbase.org. (B) The sequences of mature HIV-1 microRNA variants as determined by several methods
including: Bp, bioinformatic prediction; Ra, RNase protection assays; Nb, Northern blotting; Ns, next generation sequencing; Mc, molecular cloning. Please note that
sequences are not aligned accordingly; lowercase letters indicate polymorphic sites when available. The numbers before and after the nucleotide sequences refer to
the relative genomic position/s in the pre-microRNA sequences if made available by authors in literature. (C) The mRNA targets of the HIV-1 microRNAs immediately
followed by italicized letters correspond to the type of regulation, where: u = up-regulation, d = down-regulation when described in literature. In addition, if targets
are HIV-1 mRNA genes or mRNA transcripts they are typed in boldface, RNAi pathway-related gene products typed in BLUE; and literature-based standard HIV-1
linked cellular gene products are typed in RED. (D) The reported functional attributes of mRNA targets by HIV-1 microRNA among studies.
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microRNAs, bi-target co-regulation is a prospective occurrence
when a microRNA seed sequence would complement both viral
and cellular mRNAs simultaneously due to sequence similar-
ities. Though, the mechanisms of these interactivities are not
thoroughly explainable at the moment, computational analyses
suggest the probabilities of their existence, in particular during
viral infection (Veksler-Lublinsky et al., 2010).
ALTERATIONS IN CELLULAR MicroRNA EXPRESSION
DURING HIV-1 INFECTION
HIV-1 infection induced changes in cellular microRNA expres-
sions result from combinatorial molecular interactions among
proteins, transcripts, and genomes. These manifest as circuitous
microRNA attenuation of the different cellular host metabolic
processes. At this point, the current knowledge of the exact mech-
anisms on how HIV-1 infection remains to be understood fully.
The current data available are mostly derived from microarray
data comparing non-infected and HIV-1 infected cell lines. Over
expression analyses of microRNAs among various cell lines sim-
ulated with HIV-1 infection are usually used to validate these
differences in an attempt to explain the possible regulatory mech-
anisms behind the miroRNA interactions. Examples include the
(Houzet et al., 2008) investigation which reported 59 simulta-
neously down-regulated cellular microRNAs of HIV-1 infected
individuals. Prior studies indicated that HIV-1 infection can
down-regulate as much as 43% of the 312 microRNA gene arrays
(Yeung et al., 2005). In addition, unique and variable global
modifications in microRNA expressions were exhibited by dif-
ferent host cell types and lines in reaction to HIV-1 infection
(Yeung et al., 2005; Bennasser et al., 2006; Noorbakhsh et al.,
2010; Gupta et al., 2011). A most recent example is the notable
differences among the 21 microRNA profiles between the elite
long-term non-progressors where viral replication is continu-
ously suppressed against multiple uninfected individuals from
377 microRNAs changes in HIV-1 infected CD4+ lymphocytes
(Bignami et al., 2012). Determining the alterations in cellular
microRNA expression patterns among various types of HIV-1
infected cell lines may account factors such as productive infec-
tion and constant exposure to HIV-1 that drive these changes.
Also modifications in microRNA profiles may be attributed to
temporal variability of immune responses during the course of
HIV-1 infection. When fully elucidated, these patterned varia-
tions of microRNA expressions may reflect vital information in
HIV-1 disease diagnostics and progression. Currently, microarray
data has been the greatest source of these analyses of microRNA
expression pattern changes, aided by complex algorithms to
detect actual variation.
An in depth analyses of these global changes confirm the
existence of clustered microRNA expression signatures in HIV-
1 infected cells. For example, downregulation of polycistronic
microRNA hsa-miR-17/92 consistently suppressed viral produc-
tion as observed among various HIV-1 infected cells (Triboulet
et al., 2007). While, hsa-miR-27b, hsa-miR-29b, hsa-miR-150,
and hsa-miR-223 were identified as significantly down-regulated
upon CD4(+) T cell activation (Chiang et al., 2012). In contrast,
hsa-miR-28, hsa-miR-125b, hsa-miR-150, hsa-miR-223, and hsa-
miR-382, which were enriched in resting CD4+ T cells against
the activated CD4+ T cells (Huang et al., 2007). Moreover, the
T-cell-specific microRNAs, namely hsa-miR-150, hsa-miR-191,
hsa-miR-223, hsa-miR-16, and hsa-miR-146b, showed variable
expression patterns at various stages of HIV-1 infection. Recently,
gene expression profile analyses of cellular microRNAs in HIV-1
infected CD4+ T cells demonstrated the down-regulation of hsa-
miR-21, hsa-miR-26a, hsa-miR-155, hsa-miR-29a, hsa-miR-29b,
and hsa-miR-29c, contrary to the observed upregulation of hsa-
miR-223 (Sun et al., 2012). The identification of microRNA fami-
lies may hold significance in correlating the targets as orthologous
modules as previously mentioned.
HIV-1 ENCODED MicroRNAs AND THEIR INTERACTIONS
The low number of verified HIV-1 encoded microRNAs (Table 1)
in the miRBase (2012) confirm the difficulty of their identifica-
tion thus making them among the least characterized of RNA
virus-generated microRNAs (Grundhoff and Sullivan, 2011).
This scarcity may be due to their inherent low number because
of the small genome size or low levels of expression currently
undetectable by conventional biochemical techniques thus may
require enrichment processes to be detected (Althaus et al.,
2012). Previously, Lin and Cullen (2007) estimated that retro-
viral microRNAs comprise only 0.5% of the total microRNAs
detectable in HIV-1 infected cells. In addition, the limited access
of viruses to nuclear microRNA processing machinery and the
natural destabilization effects of microRNA processing may also
limit their biogenesis (Grundhoff and Sullivan, 2011). Also,
several reports confirmed the endonucleolytic effects of Dicer or
Drosha against viral RNA genomes thus reducing viral mRNA
production (Ouellet and Provost, 2010).
However, the advent of highly sensitive technologies like next
generation sequencing and RNAse protection assays (RPA), as
well as improved computational prediction may contribute to the
discovery of new HIV-1 microRNA species. Recent pyrosequenc-
ing results estimated at least 40% or 125 of the candidates as
putative HIV-1 microRNAs originating from the TAR, RRE and
nef region, and major components of non-coding RNAs in HIV-
1 infected cells (Yeung et al., 2009). The deep sequencing report
of (Schopman et al., 2012) further supports these observations, as
HIV-1 microRNAs are suggested to arise from structured regions
of the genome which facilitate Drosha and Dicer mediated RNA
processing. Hence, with the increased possibilities that many
putative HIV-1 microRNAs identified by these breakthrough pro-
cedures, they require further investigations on their isolation and
functional characterization.
In general, the target interactions of HIV-1 microRNAs with
its mRNA seem to function as viral genome regulators (Table 1).
However, current experiments open this into a subject of debate
and further investigation. Although, functional studies suggest
auxiliary functions of HIV-1 microRNAs which target host cel-
lular transcripts mainly for immune evasion (Boss and Renne,
2011). These observations are explained further in succeeding
discussions below.
HIV-1 TAR MicroRNA
The 50 nt HIV-1 TAR element within the 5′ region of the viral
RNA serves as the progenitor of hiv1-miR-TAR via asymmetrical
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processing of the transcript (Ouellet et al., 2008). Experiments
confirmed hiv1-miR TAR to target host cell microRNA-related
proteins, namely, Dicer, trans-activation responsive RNA binding
protein (TARBP2, TRBP), and the RNA induced transcriptional
silencing (RITS) complex. Recent functional studies showed that
HIV-1 TAR microRNA down-regulates the DNA excision repair
(ERCC1) and radiation-inducible immediate-early gene IEX-1
proteins (IER3) thus exerting its anti-apoptotic effect in infected
cells (Klase et al., 2009).
Computer simulation studies established the HIV-1 TAR ele-
ment as a potential microRNA rich region because of the follow-
ing evidences (Narayanan et al., 2011): (a) the hairpin formation
of the TAR element concurs with Dicer substrate specifica-
tions, allowing the complement fit to five distinct Dicer element,
(b) TAR binds to important microRNA proteins, Dicer, and
TARBP2, thus singling out its essential role in the microRNA-
mediated gene regulatory processes. Moreover, the TARBP2 asso-
ciation with Dicer is necessary for efficient loading of microRNAs
into the RISC, the consequential loss of TARBP2 function cul-
minates in the loss of RNA silencing ability (Sanghvi and Steel,
2011a). The TARBP2 sequestration is known to restrict the avail-
ability of Dicer enzyme leading to modification of microRNA
processing (Haase et al., 2005). Furthermore, TARBP2 and TAR
element association suppresses interferon (IFN)-induced protein
kinase R function (Gatignol et al., 2005)
Cloning studies of TAR-related microRNAs demonstrated a
greater abundance of the 3′ mature sequence over the 5′ mature
sequences involved in microRNA-derived silencing (Lamers et al.,
2010). These observations collectively suggest that, in infected
cells, hiv1-miR-TAR-3p is superior to the hiv1-miR-TAR-5p in
suppressing gene expression, supporting speculations that there
are preferential releases of these microRNA species. This also cor-
roborates to the evident accumulation of the 3′ HIV-1 TAR RNAs
in vivo (Ouellet et al., 2008).
HIV-1 H1 MicroRNA
The 81bp stem loop of HIV-1 transcript formed in the 3′-U3
(LTR) region known as the binding sites of the two nuclear fac-
tor kappa-light-chain-enhancer of activated B cells (NF-kB) is the
origin of hiv1-miR-H1 (MI0006106). It was shown to degrade
apoptosis antagonizing factor (AATF) which decreases cell via-
bility and reduced expression of cellular factors, Bcl-2, c-myc,
Par-4 as well as the microRNA Dicer protein (Kaul, 2007; Kaul
et al., 2009). The report also indicated hiv1-miR-H1 interac-
tion with hsa-mir-149, affecting the latter’s target HIV-1 encoded
Vpr protein (Kaul et al., 2009). It is assumed that hiv1-miR-H1
and hiv1-miR-TAR are antagonistic to one another as they have
contrasted activities against apoptotic elements. Further func-
tional studies demonstrated deletion-driven evolution patterns in
hiv1-miR-H1 among various AIDS patients. In addition, causal
association was suggested between the appearance of a less stable
hiv1-miR-H1 variant and induction of AIDS-related lymphoma
(Lamers et al., 2010).
HIV-1 NEF MicroRNA
Nef protein has been shown to downregulate cell surface CD4 and
MHC class I molecules through the clathrin-mediated endocytic
pathway (Lubben et al., 2007; Schaefer et al., 2008). It is also
involved in cellular signal transduction pathway through inter-
action with non-receptor type Tyr kinase molecules such as, Fyn
and Lyn. Since, Nef functions in favor of HIV-1 replication and
it is relatively conserved among various HIV-1 variants, miRNA-
mediated control of Nef could have a great effect on the viral
life cycle and its pathogenesis (Arien and Verhasselt, 2008; Foster
and Garcia, 2008; Malim and Emerman, 2008). Although, HIV-1
3′ LTR is partially overlapping with nef microRNA (hiv1-miR-
N367), as proposed previously (Omoto and Fujii, 2005, 2006), it
remained controversial due to its non-duplicability. These reports
may support a hypothesis of hyper-evolution of HIV-1 genome as
a consequence of peptide-based immunity and RNA interference
mechanisms (Narayanan et al., 2011).
HIV-1 ANTISENSEMicroRNAs
Recent reports have indicated the ability of HIV-1 utilizing anti-
sense transcripts in infected cells leading to discoveries of new
viral microRNAs. In the RACE analyses of HIV-1 infected 293T
and Jurkat cells, it was shown that cryptic transcription initi-
ation sites in the 5′ border of the 3′ LTR and a new poly A
signal within this LTR were present; also indicated was the pos-
sible role of the Tat protein as the modulator of transcription of
this antisense RNA (Landry et al., 2007). In another study, an
antisense peptide open reading frame (ORF) called “asp” coding
for a hydrophobic protein was derived from Jurkat cells infected
with HIV-1 although its origin, generation or the function is
not yet clarified (Clerc et al., 2011). As the existence of anti-
sense HIV-1microRNAs remains to be proven, this concept opens
a possibility where long antisense transcripts can complement
with the sense transcripts within the viral genome. These sites
in double stranded configuration can provide biogenic zones of
Dicer-mediated microRNAs (Houzet and Jeang, 2011).
CELLULAR MicroRNAs INVOLVED IN HIV-1 INFECTION
HIV-1 infection triggers multi-modal cascades of host cell
microRNA targeting interactions that either activate or inhibit
viral invasion and replication as shown in Figure 1. These
microRNA targeting scenarios are likely to occur on at least two
fronts. First, the cellular microRNA might directly target the
HIV-1 genome, either in sense or antisense orientation, to sup-
press the production of viral proteins. An outstanding example
is hsa-miR-29 which targets the HIV-1 nef transcript (Hariharan
et al., 2005; Ahluwalia et al., 2008). Since, the HIV-1 nef gene is
located at the proviral DNA 3′ portion, cellular microRNA tar-
geting of this region would have serious implications in the viral
life cycle. The group of (Nathans et al., 2009) proved that ectopic
expression of hsa-miR-29 can repress production of nef protein
resulting to suppressed viral replication and infectivity. The study
also reported that hsa-mir-29a/ HIV-1 interactions enhance viral
mRNA associations with RISC and P-body structures, thus sug-
gesting prospective roles of P-bodies to viral latency regulation. In
another study, a set of microRNAs namely, hsa-mir-28, hsa-miR-
125b, has-miR-150, hsa-miR-223, and hsa-miR-382 were shown
to bind in the 3′ position of HIV-1 transcripts which triggers viral
latency (Huang et al., 2007). Recently, Sun et al identified another
set of cellular microRNA, namely hsa-miR-15a, hsa-miR-15b,
www.frontiersin.org August 2012 | Volume 3 | Article 306 | 7
Tan Gana et al. MicroRNAs in HIV-1 infection
hsa-miR-16, hsa-miR-24, hsa-miR-29a, hsa-miR-29b, hsa-miR-
150, and hsa-miR-223 that are directly targeting HIV-1 3′-UTR,
and exhibiting weak but significant inhibitory effects on HIV-
1 replication (Sun et al., 2012). In a review by Sun and Rossi,
using the PITA software, 256 seed-match sites were identified to
complement Nef-3′ LTR sequence (Sun and Rossi, 2011).
In the second scenario, the host cell as triggered by HIV-1
infection would initiate cellular microRNA production to attenu-
ate cellular factors involved in antiviral responses against HIV-1.
Table 2 summarizes the list of cellular microRNAs with their
validated host cellular protein targets and their corresponding cel-
lular functions. As likely initial repercussions, these microRNAs
may target the genes involved in immune responses for innate
and adaptive immunity (Kulpa and Collins, 2011). This bipartite
defense system initially triggers natural killer (NK) cell activities
as elicited by partial detection of HIV-1 components. In a later
reaction, adaptive immunity is induced through production of
antigen-specific antibodies by B-cells and eliciting cell-mediated
immunity through antigen-specific cytotoxic T lymphocytes, of
which microRNAs were found to target various cellular receptors
(Cobos-Jimenez et al., 2011). As examples are cellular microRNA
interactions with chemokines (Zhou et al., 2010).
Transcriptional control is vital to theHIV- 1 proliferation, thus
determining microRNA interactions among host transcription
factors and regulators is a necessity (Victoriano and Okamoto,
2012). Among examples are reporter assays suggesting hsa-miR-
223 bi-functional effects in HIV-1 replication are targets were
varied in two different cell lines namely, Sp3 and LIF in NB4
cells, while RhoB and NF-1A in HEK293 cells (Sun et al., 2012).
Next is the hsa-miR-29 family which also targets cellular proteins
Mcl-1, DNMT 3A/B, Tcl1, p85, and CDC42, further establishes
its diverse roles in HIV-1 latency (Sun et al., 2012; Witwer et al.,
2012). Another is hsa-miR-198 targeting CCNT1 (Kaul et al.,
2009), a key component in the Tat-mediated transcription of the
virus, when suppressed can impair HIV-1 replication (Imai et al.,
2009).
Table 2 | List of published cellular microRNAs and their target HIV-1 and cellular gene products.
Cellular microRNA
Name (A)
Gene product (mRNA)
targets (B)
Function (C) References
hsa-let-7/ g∗ DICER
LIN28
IL-10
Pre-microRNA processing/microRNA binding
Pre-microRNA processing regulation; repress
maturation of hsa-let-7 family; blocks Drosha
and Dicer processing of pri-/pre hsa-let-7
family via interaction with terminal loop; blocks
Dicer processing of pre- hsa-miR-128
Inflammatory response
Faller and Guo, 2008; Faller et al.,
2010; Desjardins et al., 2012;
Swaminathan et al., 2012
hsa-miR-17∗ /17-3p
hsa-miR-17/17-5p
EP300/CBP associated
factor (PCAF) u
KAT8
HA Tat co-factor
Transcription factor and regulator/control of
viral replication
HIV-1 Tat interactive protein
HIV-1 Tat interactive protein
Triboulet et al., 2007; Hayes et al.,
2011
hsa-miR-92a-1∗ HA Tat cofactor HIV-1 Tat interactive protein Sun et al., 2012
hsa-miR-125b-5p
hsa-miR-125b-1∗/125b-2∗
hsa-miR-125a-5p
hsa-miR-125a-3p
Nef-3′ UTR LTR Viral replication and promotion of viral latency
in T-cells
Huang et al., 2007; Witwer et al.,
2012
hsa-miR-128 SNAP25 Cellular receptor Eletto et al., 2008
hsa-miR-146 CCL8/MCP-2 Innate immune response factor Rom et al., 2010
hsa-miR-149 Vpr Regulation of nuclear import of HIV-1
pre-integration complex; viral replication and
cellular immune suppression
Kaul et al., 2009
hsa-miR-150/150∗ 3′ end of HIV-1 RNA
APOBEC3G/3F d
CCR5
CD4 d
CCNT1
Viral replication and promotion of viral latency
in T-cells
Cellular co-factor; relieves microRNA
repression mechanisms
HIV-1 receptor and natural ligand
HIV-1 receptor and natural ligand
Repression of HIV-1 tat co-factor for
transcriptional trans-activation
Huang et al., 2007; Witwer et al.,
2012
hsa-miR-155 Target not specified Function not specified Sun et al., 2012
(Continued)
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Table 2 | Continued.
hsa-miR-198 CCNT1 (P-TEFb) d Repression of HIV-1 Tat co-factor
for transcriptional trans-activation
Sung and Rice, 2009
hsa-miR-20a PCAF u
KAT8
MCL1
DNMT3A/B
TCL1A
PIC3R1
CDC42
Co-factor of Tat trans-activation.
Cellular transcription activator
Cellular anti-apoptotic factor
Cellular transcriptional regulator
Interacts with IKB
PI3 kinase subunit
HIV-1 receptor and natural ligand
Hayes et al., 2011
hsa-miR-21 Target not specified Function not specified Sun et al., 2012
hsa-miR-27a∗ /27a
hsa-miR-27b∗ /27b
CCNT1 Transcription factor and regulator;
repression of HIV-1
Tat co-factor for transcriptional
trans-activation
Chiang et al., 2012
hsa-miR-28-5p/28-3p 3′ end of HIV-1 RNA
CCR5
CD4 d
APOBEC3G/3F d
Viral replication and promotion of
viral latency in T-cells
HIV-1 receptor and natural ligand
HIV-1 receptor and natural ligand
Cellular co-factor
Huang et al., 2007; Swaminathan
et al., 2009
hsa-miR-29a/29a∗
hsa-miR-29-b1∗ /29b1d /29-b2∗
hsa-miR-29c∗ /29c
Nef protein coding mRNA
3′-UTR (420)
RISC, P bodies
MCL-1
DNMT 3A/B
TCL1a,
p85a
CDC42
CCNT1
Viral replication and latency
Viral replication and latency
Mature microRNA
assembly/carrier
Cellular anti-apoptotic factor
Cellular transcriptional regulator
Interacts with IKB
PI3 kinase subunit
HIV-1 receptor and natural ligand
Transcription factor and regulator;
repression of HIV-1
Tat co-factor for transcriptional
trans-activation
Ahluwalia et al., 2008; Nathans
et al., 2009; Chiang et al., 2012; Sun
et al., 2012; Witwer et al., 2012
hsa-miR-217 SIRT1 Cellular stress response regulator Zhang et al., 2012
hsa-miR-223∗ /223 3′ end of HIV-1 RNA
APOBEC3G/3F d
P3 d
LIF d
RobB d
CCNT1
Viral replication and promotion of
viral latency in T-cells
Cellular co-factor
Cellular co-factor
Cellular co-factor
Cellular co-factor
Transcription factor and regulator
Huang et al., 2007; Swaminathan
et al., 2009; Chiang et al., 2012; Sun
et al., 2012
Chiang et al., 2012
hsa-miR-31/31∗ Target not specified Function not specified Witwer et al., 2012
hsa-miR-34a CREBBP Transcription factor and regulator Chiang et al., 2012
hsa-miR-382 3′ end of HIV-1 RNA Viral replication and promotion of
viral latency in T-cells Huang et al., 2007
Notes: (A) The official names of microRNAs as published in mirbase.org. The microRNAs in boldface are the dominant targeting species when reported in literature.
(B) The mRNA targets of the HIV-1 microRNAs are immediately followed by italicized letters which correspond to the type of regulation, where: u = up-regulation,
d = down-regulation when described in literature. In addition, if targets are HIV-1 mRNA genes or mRNA transcripts they are typed in boldface, RNAi pathway-
related gene products typed in BLUE; and literature-based standard HIV-1 linked cellular gene products are typed in RED. (C) The reported functional attributes of
mRNA targets by HIV-1 microRNA among studies.
Cellular microRNAs linked to chromatin regulation show
proof that microRNAs are critical elements of epigenetic con-
trol in HIV-1 infection (Obbard et al., 2009; Easley et al.,
2010). Recent evidences support that chromatin modification
may explain mechanisms of HIV-1 transcription and thus the
maintenance of latency. Some microRNA species are consid-
ered involved in gene silencing by modulating methylation and
deactylation of histone proteins (Triboulet et al., 2007).
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The above mentioned functional gene product clusters are just
few focal points of cellular microRNA interactivities related to
HIV-1 infection. It is expected that as more interactions are vali-
dated, the complex nature of cellular microRNA regulation linked
to HIV-1 infection and host response would be further character-
ized. However, the scope of cellular microRNA interactions may
involve other non-listed prospective gene targets which may also
influence HIV-1 infection.
BEYOND CROSSTALKS AMONG CELLULAR AND HIV-1
MicroRNA MACHINERIES
Preceding discussions on microRNA interactions in host-HIV-1
infection further confirm their inherent complexity. It perfectly
illustrates the constant attenuation of gene regulatory networks
to maintain homeostasis in the HIV-1 infected cells. However,
as HIV-1 remains an incurable disease among humans, it is
implied that it can successfully compromise host immune and
defense reactions wherein microRNA regulation might play piv-
otal roles. Thus, future studies must focus on how to reprogram
microRNAs to favorably initiate the cellular anti-HIV-1 defense
response. To realize such goal, it becomes necessary to orga-
nize succeeding investigations as follows: First is to globally
account cellular and viral microRNA interrelationships affecting
biomolecular pathways in HIV-1 infection. This allows the pos-
sibility of unlocking the combination of molecular switches that
would allow the host cell successfully defend itself against HIV-1.
Second is to determine the simultaneous targets of viral and cel-
lular microRNAs. These bi-targets may reveal signatures of gene
families or microRNA clusters characterizing HIV-1 infection
patterns. Third is to capture temporal changes among microRNA
expression patterns during HIV-1 disease progression. In assess-
ing the current amount of information on hand, there remains
much work to be done in unlocking the ultimate roles of microR-
NAs in HIV-1 pathogencity.
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